These are challenging times for governments, public health administrations and the financial markets. While each biopharma company’s primary concern is the health and safety of its team members, the industry also a responsibility to the world to take an active role in alleviating human disease and suffering.
Here at Locust Walk, we have a unique view into the strategic implications of COVID-19 on the fortunes of our industry’s most innovative companies.
We also know that there are many questions relative to the prospects for success in the near term from different types of biopharma companies. We have compiled a list of recommendations by company type for management teams and boards to consider. As it has been since our founding during the last major economic crisis, Locust Walk stands prepared to help our clients through this turbulent time with actionable strategic recommendations and high-quality deal execution across strategic transactions and private placements.
We hope these thoughts are helpful to you. Please do not hesitate to reach out to us further. Click below to read immediately.
The Locust Walk Team